Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide COOL-AF Registry

Background: Warfarin remains the most commonly used oral anticoagulant (OAC) in Thailand for stroke prevention among patients with non-valvular atrial fibrillation (NVAF). The aim of this study was to investigate the relationship between time in therapeutic range (TTR) after warfarin initiation and...

Full description

Bibliographic Details
Main Authors: Rungroj Krittayaphong, Thoranis Chantrarat, Roj Rojjarekampai, Pongpun Jittham, Poom Sairat, Gregory Y.H. Lip
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Journal of Clinical Medicine
Subjects:
TTR
Online Access:https://www.mdpi.com/2077-0383/9/6/1698